(AS OF MARCH 31)
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/15/2024 | Q1 2024 | -$0.20 | $15,928 | 04/01/2024 | Q4 2023 | -$0.07 | $5,310 | 11/13/2023 | Q3 2023 | -$0.16 | $10,030 | 08/14/2023 | Q2 2023 | -$0.39 | $1,725 | 05/15/2023 | Q1 2023 | -$0.11 | $0 | 03/31/2023 | Q4 2022 | -$0.25 | $950 | 09/29/2022 | Q3 2022 | -$0.12 | $0 | 06/30/2022 | Q2 2022 | -$0.09 | $0 | 03/31/2022 | Q1 2022 | -$0.03 | $0 | 06/30/2021 | Q2 2021 | -$0.01 | $0 | 03/31/2021 | Q1 2021 | -$0.01 | $0 |
---|
A. The conference call for Cardio Diagnostics Holdings, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Cardio Diagnostics Holdings, Inc.'s latest earnings report can be read online.
A. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) has a recorded annual revenue of $17,065.
A. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) has a recorded net income of $17,065. Cardio Diagnostics Holdings, Inc. has generated $-0.66 earnings per share over the last four quarters.
A. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) has a price-to-earnings ratio of -1.01 and price/earnings-to-growth ratio is -0.03.